Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week
Motley Fool
Monday, April 25, 2011 - 11:15am
tags:
Vertex Pharmaceuticals, Merck, Boceprevir, Telaprevir, hepatitis C
A Fight Over How Drugs Are Pitched
NY Times, NY
Monday, April 25, 2011 - 10:42am
tags:
drug reps, physicians
Earnings Preview: Hospira
Yahoo/Zacks.com
Monday, April 25, 2011 - 10:36am
tags:
earnings, Hospira
Why The FDA Issues More Refuse To File Letters
Pharmalot
Monday, April 25, 2011 - 9:38am
tags:
FDA, RTF letters, refuse to file letters
Something to Like About ViroPharma: Management Stock Ownership
Seeking Alpha
Monday, April 25, 2011 - 9:33am
tags:
ViroPharma
Sun Pharma to sell some Merck diabetes drugs in India
Reuters
Monday, April 25, 2011 - 9:21am
tags:
Merck, diabetes, India, Sun Pharma
Spectrum Pharmaceuticals: Pending Approvals Could Send This Stock Flying
Seeking Alpha
Monday, April 25, 2011 - 9:19am
tags:
Spectrum Pharmaceuticals, Fusilev, osteosarcoma
FDA says highly anticipated Merck drug achieved goal of eliminating traces of hepatitis C
Yahoo/AP
Monday, April 25, 2011 - 9:17am
tags:
Merck, FDA, hepatitis C, Boceprevir
Pharmasset 2Q loss widens on costs
Yahoo/AP
Monday, April 25, 2011 - 9:16am
tags:
earnings, Pharmasset
Botox May Deaden Ability to Empathize, New Study Says
Forbes
Monday, April 25, 2011 - 9:15am
tags:
Botox, Allergan
Eisai Aricept Patch for Alzheimer’s Isn’t Ready for Approval
Bloomberg
Monday, April 25, 2011 - 9:14am
tags:
Eisai, Aricept, Alzheimer's disease, Aricept patch
Johnson & Johnson Looks Promising on New Product Potential
Seeking Alpha
Monday, April 25, 2011 - 9:13am
tags:
JNJ
Pfizer Deal Allows Dr. Reddy’s to Sell Depression Pill in U.S.
Bloomberg
Monday, April 25, 2011 - 9:12am
tags:
Dr Reddy's, Pfizer, Wyeth, generics, Effexor XR, antidepressants
GW Pharma gets US patent for Sativex in cancer pain
pharmabiz
Saturday, April 23, 2011 - 11:18am
tags:
GW Pharma, Sativex, pain management
Baxter's First Quarter Financial Results Exceed Guidance
PharmPro
Saturday, April 23, 2011 - 11:16am
tags:
Baxter International, earnings
Pfizer, Shanghai Pharma sign MoU for potential strategic partnership
pharmabiz
Saturday, April 23, 2011 - 11:15am
tags:
Pfizer, Shanghai Pharmaceutical
GlaxoSmithKline Biologicals looking to acquire Biological E Limited's vaccine division
Invest In India
Saturday, April 23, 2011 - 11:14am
tags:
GSK, Biological E, vaccines
Watson confirms Welchol patent challenge
pharmabiz
Saturday, April 23, 2011 - 11:13am
tags:
Watson Pharmaceuticals, Welchol, Daiichi Sankyo, Genzyme
Biogen Idec's MS Drug Appears to Have an Edge
Motley Fool
Saturday, April 23, 2011 - 11:09am
tags:
Biogen Idec, multiple sclerosis, BG-12, Gelenya, Novartis
Valeant Pharmaceuticals Responds to Cephalon Board's Letter
Bradenton Herald, FL
Saturday, April 23, 2011 - 11:08am
tags:
Valeant Pharmaceuticals, Cephalon, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.